Genesis Fertility Center PCL
SET:GFC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (10.6), the stock would be worth ฿4.91 (71% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 6.2 | ฿2.88 |
0%
|
| 3-Year Average | 10.6 | ฿4.91 |
+71%
|
| 5-Year Average | 10.6 | ฿4.91 |
+71%
|
| Industry Average | 9.2 | ฿4.25 |
+48%
|
| Country Average | 8.6 | ฿3.99 |
+39%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
฿566.1m
|
/ |
Jan 2026
฿84.1m
|
= |
|
|
฿566.1m
|
/ |
Dec 2026
฿80.3m
|
= |
|
|
฿566.1m
|
/ |
Dec 2027
฿92.4m
|
= |
|
|
฿566.1m
|
/ |
Dec 2028
฿113.1m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| TH |
G
|
Genesis Fertility Center PCL
SET:GFC
|
633.6m THB | 6.2 | 28.3 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
89.1B USD | 13.3 | 50.4 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68B EUR | 7.8 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
69B USD | 0 | 11.6 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
24.8B EUR | 9.3 | 19.5 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.5B EUR | 9 | 23.3 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 11.9 | 24.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.5B USD | 11.8 | 21.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR | 5.3 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.1B USD | -29.1 | -26.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 7.3 | 14.2 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 6.6 |
| Median | 8.6 |
| 70th Percentile | 11.4 |
| Max | 3 584.8 |
Other Multiples
Genesis Fertility Center PCL
Glance View
Genesis Fertility Center PCL is a TH-based company operating in Health Care Providers & Services industry. The company is headquartered in Bangkok, Bangkok Metropolis. The company went IPO on 2023-09-13. Genesis Fertility Center PCL is engaged in providing clinical medical services for individuals who are facing infertility. The firm provides solutions and recommends appropriate treatments, such as intracytoplasmic sperm injection (ICSI), in vitro fertilization (IVF), and egg freezing. Its comprehensive services cover all aspects of infertility treatment, including diagnosing the root causes and selecting the suitable treatment options. The company provides advice on both physical and mental preparations to increase the chances of successful conception. The company also offers egg deposits, embryo chromosome check-ups, and premarital health check-ups. The firm offers services, such as artificial insemination (AI), embryo transfer, testicular sperm extraction, oocyte freezing, and pre-implantation genetic diagnosis. AI is the deliberate introduction of sperm into a female’s uterus for the main purpose of achieving a pregnancy through in vivo fertilization by means apart from sexual intercourse.
